OMT-004

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOMT-004
Drug Alias NameOMT-004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIsocitrate dehydrogenase [NADP] cytoplasmic inhibitorsBromodomain-containing protein 2 inhibitors
TargetsIsocitrate dehydrogenase [NADP] cytoplasmicBromodomain-containing protein 2
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOhm oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesOhm oncology Inc
Inactive CompaniesN/A
Active IndicationsGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A